Marketing Authorisation Holder
CEVA SANTE ANIMALE SA
FOREIGN
13
Total Medicines
13
Active
8
Dosage Forms
1
Country
Kenya
(13)
Registration Status
Registered
13
Dosage Forms
SPIRAMYCIN …… 60MIU/100ML OR 600 000 IU PER ML
1
NEWCASTLE DISEASE VIRUS STRAIN PHY.LMV.42 AT LEAST 5.5 LOG10 EID50 AVIAN INFECTIOUS BRONCHITIS VIRUS STRAIN H120 AT LEAST 3.3 LOG10 EID50
1
MIN. 2.8 LOG10 EID50 PER DOSE
1
MAREK’S DISEASE, HVT STRAIN…………AT LEAST 2164 PFU PER DOSE THROUGH EXPIRATION. MAREK’S DISEASE, RISPENS CVI988 STRAIN……….. AT LEAST 1322 PFU PER DOSE THROUGH EXPIRATION. WITH CRYOPROTECTANTS: CRYOPROTECTANT NO. 1 + HVT AND RISPENS CVI988 STRAINS..…….50-90%
1
MARBOFLOXACIN 100MG/ML
1
INACTIVATED NEWCASTLE DISEASE VIRUS STRAIN NDV-SZ LASOTA ………………… INDUCING MIN. 5 LOG2 HI TITER OR MIN. 50 PD50 IN CHALLENGE
1
INACTIVATED NEWCASTLE DISEASE VIRUS STRAIN NDV-SZ LASOTA …….. INDUCING MIN. 4 LOG2 HI OR MIN. 50 PD50
1
INACTIVATED AND CONCENTRATED NEWCASTLE DISEASE VIRUS, B1 TYPE MIN 108.8 EID50 INACTIVATED AND CONCENTRATED INFECTIOUS BRONCHITIS VIRUS MASSACHUSETTS TYPE, STRAIN M-41 MIN 106.1 EID50 INACTIVATED AND CONCENTRATED INFECTIOUS BRONCHITIS VIRUS MASSACHUSETTS T
1
Therapeutic Classes
GENERIC/BIOSIMILARS
10
NEW/INNOVATOR
3
Local Agents / Applicants
CEVA SANTE ANIMALE SA
13
Registered Medicines
Showing 13 of 13